9104 Randomized phase III study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carboplatin (PC) with concurrent thoracic radiotherapy (CTR) for patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC): West Japan Thoracic Oncology Group (WJTOG) 0105

✍ Scribed by Katakami, N.; Satouchi, M.; Yamamoto, N.; Imamura, F.; Saka, H.; Iwamoto, Y.; Saito, H.; Nishimura, Y.; Chiba, Y.; Nakagawa, K.

• Book ID: 123491842
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 67 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71817-8